Medicare Enrolled

Dr. Rex Marco, M.D.

Orthopedic Surgery · Houston, TX
Consulting-driven
6445 MAIN ST, Houston, TX 77030
7133637510
In practice since 2006 (19 years)
NPI: 1205861887 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marco? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marco

Dr. Rex Marco is an orthopedic surgery specialist in Houston, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Marco received a total of $218,226 from 21 pharmaceutical and/or device companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in orthopedic surgery. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marco is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $218,226 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$218,226
Total received (2018-2024)
Avg $31,175/year across 7 years
Top 5% in TX for orthopedic surgery
21
Companies
214
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$169,538 (77.7%)
Scientific / Research
Research funding and grants
$23,112 (10.6%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$14,077 (6.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,397 (5.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$101 (0.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,433
2023
$33,923
2022
$74,196
2021
$3,146
2020
$9,904
2019
$42,537
2018
$49,086

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medical Device Business Services, Inc.
$76,976
Stryker Corporation
$43,082
DePuy Synthes Sales Inc.
$34,165
NuVasive, Inc.
$25,230
Cerapedics Inc.
$21,214
Globus Medical, Inc.
$14,077
DePuy Synthes Products LLC
$1,030
Medtronic, Inc.
$936
Alphatec Spine, Inc
$452
K2M, Inc.
$176
Medtronic USA, Inc.
$139
SI-BONE, INC.
$133
Heron Therapeutics, Inc.
$124
Kuros Biosciences USA, Inc
$124
Wound Management Technologies, Inc
$81
Carlsmed, Inc.
$75
Pacira Pharmaceuticals Incorporated
$59
Ethicon US, LLC
$56
WRIGHT MEDICAL TECHNOLOGY, INC.
$46
3M Company
$33
Johnson & Johnson Health Care Systems Inc.
$19
Top 3 companies account for 70.7% of total payments
Associated products mentioned in payments ›
ACF · AERO · AIRO · AQUAMANTYS · BASE · Bair Hugger Temperature Monitoring System (SpotOn) · COHERE · CONDUIT · COUGAR · CellerateRx · Colosseum · EVEREST SPINAL SYSTEM · EVEREST Spinal System · EXPAREL · EXPEDIUM · Excelsius Deformity · Exparel · Foot and Ankle · General K2M Product Discussion · I-FACTOR PEPTIDE ENHANCED BONE GRAFT · LessRay · MATRIX · MAZOR X SYSTEM · MESA SPINAL SYSTEM · MONOVISC · Mesh Corpectomy Cage · NAVIGATION · Osteocel · Other - Miscellaneous · POWER · RELINE · SERRATO · SYMPHONY · SYNAPSE · TRITANIUM · Teligen · UNID_PASS · USS · VIPER · XLIF · ZYNRELEF · aprevo · iGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (78%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for orthopedic surgery in TX.

Looking for an orthopedic surgery specialist in Houston?
Compare orthopedic surgeons in the Houston area by procedure volume, costs, and industry payment transparency.
Browse orthopedic surgeons nearby

Geographic Context

Orthopedic surgeons within 10 mi
309
Per 100K population
6.5
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Marco is an orthopedic surgery specialist, with consulting-driven industry engagement in the top 5% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Marco receive payments from pharmaceutical companies?
Yes. Dr. Marco received a total of $218,226 from 21 companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Marco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →